EATG » Hepatitis

Hepatitis

Hepatic steatosis worsens faster in HIV mono-infection than HIV/HCV

Hepatic steatosis progressed faster and was more often associated with liber fibrosis progression among patients with HIV mono-infection compared with patients with HIV/hepatitis C coinfection, according to recently published data…

Short course of HBIG plus long-term antivirals may prevent HBV reinfection after transplant

A very short course of hepatitis B immunoglobulin (HBIG) after liver transplantation, along with long-term antiviral therapy, may prevent hepatitis B virus (HBV) reinfection, a retrospective study suggests. "We believe…

Costs for generic hepatitis C drugs available in India would be paid back in 5 to 10 years

Treatment with generic directly-acting antiviral drugs available in India increases lifespan while reducing lifetime health care costs Use of the generic versions of directly-acting antiviral (DAA) drugs that are available…

Hepatitis C virus reinfection is uncommon after being cured with DAAs

Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of…

A new collaborative project will design a graphene sensor to diagnose hepatitis

A collaborative project, supported by the UK’s Newton Fund and led by BIOVICI, will bring together the National Physical Laboratory (NPL), the University of Chongqing in China, Swansea University and…

Harvoni safe, effective for HCV–infected patients with sickle cell disease

Harvoni, a fixed-dose combination of ledipasvir and sofosbuvir, safely and effectively treated hepatitis C virus infection in patients with sickle cell disease, according to findings from a small study published…

Sofosbuvir plus ribavirin cures teens with genotype 2 or 3 hepatitis C

A 2-drug regimen of sofosbuvir (Sovaldi) and ribavirin taken for 12 weeks led to sustained virological response in all treated adolescents with hepatitis C virus (HCV) genotype 2, while a…

Post-LT biopsies show histologic features of HCV following SVR

Results of a retrospective analysis showed histologic changes associated with active hepatitis C in patients who had achieved sustained virologic response following liver transplantation for chronic HCV. “The number of…

2017 Post-EASL Report

As chronic hepatitis C virus (HCV) drug development approaches the end-game following the launch of the first pan-genotypic regimen Epclusa (; Gilead), recent and upcoming advances in chronic…

HepHIV 2017 Conference call to action and proceedings

The HepHIV 2017 Conference: HIV and Viral Hepatitis: Challenges of Timely Testing and Care was held by HIV in Europe, in collaboration with European stakeholders, from 31 January - 2…